This filing describes a 'Power Inflow' signal for Moderna (MRNA) shares, indicating a shift towards buying activity from both retail and institutional investors. The signal, triggered after an initial price decline, preceded a 3.38% intraday rise, suggesting a short-term bullish momentum based on order flow analytics.
The filing highlights a 'Power Inflow' signal for Moderna (MRNA) at 11:30 AM EST on September 30, at a price of $186.46, following an initial 5% decline. This signal, generated by TradePulse's proprietary order flow analytics, indicated a strong shift towards buying activity from both retail and institutional traders. Subsequently, MRNA's stock price rose to $192.76, a 3.38% increase, demonstrating the potential for short-term bullish momentum and a price reversal. This event is significant for active traders who utilize order flow data to identify potential entry points, offering a short-term trading opportunity based on technical indicators rather than fundamental news.